Strategic Report | Governance | Financial Statements | 15
PRODUCTS AND SERVICES
Our products and services are distributed via our multi-channel model.
RISK SELECTION Selecting the optimal risks and establishing suitable pricing for our products PrognoSys™ is our powerful proprietary tool for individual medical underwriting that drives pricing and reserving that allows the Group to identify and price for the risks we want and to improve customer outcomes. Also, because we operate in attractive markets that are growing, this further allows us to be selective in the risks we choose to write. INVESTMENT STRATEGY Continuous evolution of our investment strategy enables our business to generate value for shareholders and better outcomes for customers We invest in infrastructure loans, private placements, commercial property mortgages and social housing, as well as investment grade fixed income securities such as government and corporate bonds. We originate lifetime mortgages to provide matching cash flows for longer duration liabilities and to achieve a higher return than liquid financial assets. Read about our sustainable investment strategy in the “Sustainable investment strategy” section on page 36. INNOVATION We innovatively utilise reinsurance tools to improve our capital position This includes: • Defined benefit de-risking partnering model. • Reinsurance options on new and existing business. • No-negative equity guarantee hedge risk transfer solution.
Powered by FlippingBook